Abstract
Rats were chronically administered either haloperidol (HAL) or fluphenazine (FLU) via depot injections for 8 months, given these same drugs in their drinking water for the next 2 months, and then withdrawn from the drugs. Throughout the experiment the animals were tested repeatedly in an enclosed tube using a computerized device which measured computer-scored movelets (CSMs) and, in the latter half of the experiment, were also scored by a human observer in the tube, as well as in an open cage, for observed oral movements (OMs). In the tube, the animals in both neuroleptic-treated groups showed initial decreases in the number of CSMs and made sluggish CSMs; these effects were generally larger in the FLU animals. After 6 months of chronic neuroleptics, the HAL-treated animals showed increased oral movements, both as reported by the human observer and in CSMs of all amplitudes, and this effect increased upon drug withdrawal. FLU-treated animals showed a more persistent depression of both OMs and CSMs of large amplitudes. However, the behavior most characteristic of both neuroleptic-treated groups was the gradual development of increases in CSMs of the smallest amplitudes measurable.
A different pattern was observed in the open cage test, where both neuroleptic groups showed significant increases in vacuous OMs during drug administration which rapidly became attenuated upon drug withdrawal. These results indicate a complex syndrome of oral activity in the drugged animals which changed over time. The measure of oral activity which most clearly showed the time-course for late-onset changes in oral activity was CSMs of the smallest amplitudes.
Similar content being viewed by others
References
Barnes TR, Braude WM (1985) Akathisia variants and tardive dyskinesia. Arch Gen Psychiatry 42:874–878
Beresford R, Ward A (1987) Haloperidol decanoate: a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in psychosis. Drugs 33:31–49
Casey DE (1984) Tardive dyskinesia — animal models. Psychopharmacol Bull 20(3):376–379
Chouinard G, Annable L, Campbell W, Boisvert D, Bradwejn J (1984) A double-blind, controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance of schizophrenia. Psychopharmacol Bull 20:108–109
Clow A, Jenner P, Marsden CD (1979) Changes in dopamine-mediated behaviour during one year's neuroleptic administration. Eur J Pharmacol 57:365–375
Clow A, Theodorou A, Jenner P, Marsden CD (1980) Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration. Eur J Pharmacol 63:145–157
Curry S, Whelpton R, de Schepper R, Vranckx S, Schiff A (1979) Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate, and decanoate administration to man. Br J Clin Pharmacol 7:325–331
Ellison G, See RE, Levin ED, Kinney J (1987) Tremorous mouth movements in rats administered chronic neuroleptics. Psychopharmacology 92:122–126
Gelders YG (1986) Pharmacology, pharmacokinetics and clinical development of haloperidol decanoate. In: Silverstone T (ed) Depot antipsychotics in practice. Their role in schizophrenia and related psychoses. Int Clin Psychopharmacol [Suppl 1] 1:1–11
Gunne LM, Haggstrom JE (1983) Reduction of nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral dyskinesia. Psychopharmacology 81:191–194
Gunne LM, Andersson U, Bondesson U, Johansson P (1986) Spontaneous chewing movements in rats during acute and chronic antipsychotic drug administration. Pharmacol Biochem Behav 25:897–901
Hyttel J, Larsen JJ, Christensen AV, Arnt J (1985) Receptor-binding profiles of neuroleptics. In: Casey DE, Chase TN, Christensen AV, Gerlach J (eds) Dyskinesia, research and treatment. Psychopharmacology [Suppl] 2:9–18
Iversen SD, Howells RB, Hughes RP (1980) Behavioral consequences of long-term treatment with neuroleptic drugs. Adv Biochem Psychopharmacol 24:305–313
Jeste DV, Wyatt RJ (1982) Therapeutic strategies against tardive dyskinesia: Two decades of experience. Arch Gen Psychiatry 39:803–816
Johansson P, Levin ED, Ellison GD, Gunne LM (1987) Opposite effects of a D1 and D2 agonist on oral movements in rats. Eur J Pharmacol 134:83–88
Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93–96
Kissling W, Moller HJ, Walter K, Wittman B, Krueger R, Trenk D (1985) Double-blind comparison of haloperidol decanoate and fluphenazine decanoate effectiveness, side effects, dosage and serum levels during a six months treatment for relapse prevention. Pharmacopsychiatry 18:240–245
Knudsen P (1985) Chemotherapy with neuroleptics: clinical and pharmacokinetic aspects with a particular view to depot preparations. Acta Psychiatr Scand [Suppl] 322(72):51–75
Levin ED, Galen D, Ellison GD (1987) Chronic haloperidol effects on radial-arm maze performance and oral movements in rats. Pharmacol Biochem Behav 26:1–6
Levy AD, See RE, Levin ED, Ellison GD (1987) Neuroleptic-induced oral movements in rats: methodological issues. Life Sci 41:1499–1506
Meco G, Aniello R, Carta A, Lestingi L, Casucchia M (1984) Haloperidol decanoate (a new depot neuroleptic drug): a double blind study versus fluphenazine in schizophreniform disorders and chronic schizophrenia. Proc 14th Congr Coll Int Neuro-Psychopharmacol [abstract 135]
Rodriguez LA, Moss DE, Reyes E, Camarena ML (1986) Perioral behaviors induced by cholinesterase inhibitors: a controversial animal model. Pharmacol Biochem Behav 25:1217–1221
Rosengarten H, Schweitzer JW, Friedhoff AJ (1983) Induction of oral dyskinesias in naive rats by D1 stimulation. Life Sci 33:2479–2482
Rosengarten H, Schweitzer JW, Friedhoff AJ (1986) Selective dopamine D2 receptor reduction enhances a D1 mediated oral dyskinesia in rats. Life Sci 39:29–35
Rupniak N, Jenner P, Marsden CD (1983) Cholinergic manipulation of perioral behaviour induced by chronic neuroleptic administration to rats. Psychopharmacology 79:226–230
Rupniak N, Jenner P, Marsden CD (1985) Pharmacological characterisation of spontaneous or drug-associated purposeless chewing movements in rats. Psychopharmacology 85:71–79
Rupniak N, Jenner P, Marsden CD (1986) Acute dystonia induced by neuroleptic drugs. Psychopharmacology 88:403–419
Sant W, Ellison GD (1984) Drug holidays alter onset of oral movements in rats following chronic haloperidol. Biol Psychiatry 19:95–99
Waddington JL, Molloy AG (1987) The status of late-onset vacuous chewing/perioral movements during long-term neuroleptic treatment in rodents: tardive dyskinesia or dystonia? Psychopharmacology 91:136–137
Waddington JL, Cross AJ, Gamble SJ, Bourne RC (1983) Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment. Science 220:530–532
Waddington JL, Youssef HA, Molloy AG, O'Boyle KM, Pugh MT (1985) Association of intellectual impairment, negative symptoms and aging with tardive dyskinesia: clinical and animal studies. J Clin Psychiatry 46(4):29–33
Waddington JL, Youssef HA, O'Boyle KM, Molloy AG (1986) A reappraisal of abnormal involuntary movements (tardive dyskinesia) in schizophrenia and other disorders: animal models and alternative hypotheses. In: Winlow W, Markstein R (eds) The neurobiology of dopamine systems. Manchester University Press, Manchester, pp 266–286
Wistedt B, Wiles D, Kolakowska T (1981) Slow decline of plasma drug and prolactin levels after discontinuation of chronic treatment with depot neuroleptics. Lancet I:1163
Wistedt B, Jorgensen A, Wiles D (1982) A depot neuroleptic withdrawal study: Plasma concentration of fluphenazine and fluphenthixol and relapse frequency. Psychopharmacology 78:301–304
Wistedt B, Persson T, Hellbom E (1984) A clinical double-blind comparison between haloperidol decanoate and fluphenazine decanoate. Curr Ther Res Clin Exp 35:804–814
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
See, R.E., Levin, E.D. & Ellison, G.D. Characteristics of oral movements in rats during and after chronic haloperidol and fluphenazine administration. Psychopharmacology 94, 421–427 (1988). https://doi.org/10.1007/BF00174701
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00174701